Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Treasury Shares (2024 - 2025)

Historic Treasury Shares for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $4.1 million.

  • Kairos Pharma's Treasury Shares changed N/A to $4.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.1 million, marking a year-over-year change of. This contributed to the annual value of $278188.0 for FY2024, which is N/A changed from last year.
  • Kairos Pharma's Treasury Shares amounted to $4.1 million in Q2 2025.
  • In the past 5 years, Kairos Pharma's Treasury Shares ranged from a high of $4.5 million in Q1 2025 and a low of $278188.0 during Q3 2024